Jan Östman

1.1k total citations
24 papers, 802 citations indexed

About

Jan Östman is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Jan Östman has authored 24 papers receiving a total of 802 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Surgery and 9 papers in Genetics. Recurrent topics in Jan Östman's work include Pancreatic function and diabetes (10 papers), Diabetes and associated disorders (9 papers) and Diabetes Management and Research (9 papers). Jan Östman is often cited by papers focused on Pancreatic function and diabetes (10 papers), Diabetes and associated disorders (9 papers) and Diabetes Management and Research (9 papers). Jan Östman collaborates with scholars based in Sweden, United States and Australia. Jan Östman's co-authors include Birgitta Linde, Anders Frid, Lennarth Nyström, G. Blohmé, Hans J. Arnqvist, G. Sundkvist, Jan Bolinder, Peter Arner, Jan W. Eriksson and Mona Landin‐Olsson and has published in prestigious journals such as The Lancet, Diabetes Care and Diabetes.

In The Last Decade

Jan Östman

23 papers receiving 748 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Östman Sweden 14 467 308 276 136 88 24 802
A Teuscher Switzerland 16 642 1.4× 106 0.3× 196 0.7× 124 0.9× 132 1.5× 32 1.1k
Andrea E. Scaramuzza Italy 14 419 0.9× 233 0.8× 266 1.0× 84 0.6× 17 0.2× 18 713
Boniface J. Lin Taiwan 17 369 0.8× 142 0.5× 198 0.7× 89 0.7× 18 0.2× 42 669
Ted Wu Australia 12 533 1.1× 176 0.6× 156 0.6× 100 0.7× 34 0.4× 31 814
Fraser W. Gibb United Kingdom 20 908 1.9× 457 1.5× 344 1.2× 72 0.5× 16 0.2× 60 1.2k
Yukio Yoshimura Japan 18 352 0.8× 32 0.1× 79 0.3× 368 2.7× 52 0.6× 45 1.0k
Suzanne Strowig United States 15 462 1.0× 105 0.3× 164 0.6× 71 0.5× 9 0.1× 22 680
Margarita Torres‐Tamayo Mexico 14 233 0.5× 52 0.2× 119 0.4× 298 2.2× 34 0.4× 50 969
J. �stman Sweden 13 293 0.6× 199 0.6× 203 0.7× 83 0.6× 7 0.1× 19 529
Katherine Hurxthal United States 5 449 1.0× 109 0.4× 83 0.3× 92 0.7× 6 0.1× 8 700

Countries citing papers authored by Jan Östman

Since Specialization
Citations

This map shows the geographic impact of Jan Östman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Östman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Östman more than expected).

Fields of papers citing papers by Jan Östman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Östman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Östman. The network helps show where Jan Östman may publish in the future.

Co-authorship network of co-authors of Jan Östman

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Östman. A scholar is included among the top collaborators of Jan Östman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Östman. Jan Östman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Schölin, Anna, Carina Törn, L. Nyström, et al.. (2004). Normal weight promotes remission and low number of islet antibodies prolong the duration of remission in Type 1 diabetes. Diabetic Medicine. 21(5). 447–455. 32 indexed citations
3.
Östman, Jan, M Britton, & E Jonsson. (2004). Treating and preventing obesity: an evidence based review.. 13 indexed citations
4.
Henricsson, Marianne, Lennarth Nyström, G. Blohmé, et al.. (2003). The Incidence of Retinopathy 10 Years After Diagnosis in Young Adult People With Diabetes. Diabetes Care. 26(2). 349–354. 139 indexed citations
5.
Törn, Carina, Mona Landin‐Olsson, Åke Lernmark, et al.. (2001). Combinations of Beta Cell Specific Autoantibodies at Diagnosis of Diabetes in Young Adults Reflects Different Courses of Beta Cell Damage. Autoimmunity. 33(2). 115–120. 17 indexed citations
6.
Littorin, Bengt, G. Sundkvist, Lennarth Nyström, et al.. (2001). Family Characteristics and Life Events Before the Onset of Autoimmune Type 1 Diabetes in Young Adults. Diabetes Care. 24(6). 1033–1037. 25 indexed citations
8.
Graham, Jinko, Ingrid Kockum, Mona Landin‐Olsson, et al.. (1999). Negative association between type 1 diabetes and HLA DQB1*0602‐DQA1*0102 is attenuated with age at onset. European Journal of Immunogenetics. 26(2). 117–127. 44 indexed citations
9.
Graham, Jinko, Ingrid Kockum, Carani B. Sanjeevi, et al.. (1999). Negative association between type 1 diabetes and HLA DQB1*0602‐DQA1*0102 is attenuated with age at onset. European Journal of Immunogenetics. 26(2-3). 117–127. 52 indexed citations
10.
Östman, Jan, Åke Lernmark, Mona Landin‐Olsson, et al.. (1996). Autoimmune (Type 1) Diabetes in Young Adults in Sweden. Hormone and Metabolic Research. 28(7). 348–350. 11 indexed citations
11.
Östman, Jan, et al.. (1996). [The 1993 inventory in the county of Stockholm. Big differences when it comes to diabetic ambulatory care].. PubMed. 93(40). 3454–3454. 1 indexed citations
12.
Östman, Jan, et al.. (1995). [Diabetic care evaluated in eight counties. Sweden on its way to the European standard].. PubMed. 92(14). 1483–6. 5 indexed citations
13.
Sjöberg, Stefan, et al.. (1987). Lack of Pharmacokinetic Interaction Between Glibenclamide and Trimethoprim‐Sulphamethoxazole. Diabetic Medicine. 4(3). 245–247. 5 indexed citations
14.
Linde, Birgitta, et al.. (1986). Effects of physical exercise on insulin absorption in insulin‐dependent diabetics. A comparison between human and porcine insulin. Clinical Physiology. 6(6). 489–497. 35 indexed citations
15.
Alberti, K. G. M. M., R. Y. Calne, G. Lundgren, et al.. (1984). GRAFTED PANCREAS WITH PORTAL VENOUS DRAINAGE. The Lancet. 323(8383). 964–965. 3 indexed citations
16.
Wallberg‐Henriksson, Harriet, Rebeqa Gunnarsson, Jan Henriksson, et al.. (1982). Increased Peripheral Insulin Sensitivity and Muscle Mitochondrial Enzymes but Unchanged Blood Glucose Control in Type I Diabetics After Physical Training. Diabetes. 31(12). 1044–1050. 115 indexed citations
17.
Arner, Peter, Peter Engfeldt, & Jan Östman. (1982). Changes in the metabolism of fatty acids in adipose tissue in obese patients with primary hypertriacylglycerolemia.. Journal of Lipid Research. 23(3). 422–427. 9 indexed citations
18.
Hellerström, Claes, Arne Andersson, Ulf J. Eriksson, et al.. (1980). Isolation, culture and transplantation of human pancreatic islets. Max Planck Digital Library. 368–372.
19.
Collste, P., et al.. (1976). Plasma levels and effects of metoprolol on blood pressure, adrenergic beta receptor blockade, and plasma renin activity in essential hypertension. Clinical Pharmacology & Therapeutics. 20(2). 130–137. 58 indexed citations
20.
Östman, Jan & R D Milner. (1969). Diabetes : proceedings of the sixth Congress of the International Diabetes Federation, Stockholm, Sweden, July 30-August 4, 1967. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026